Blocking or reducing the interaction between CD24 and Siglec-10 by reducing CD24 expression via monoclonal antibodies or gene editing potently enhances the phagocytosis of tumor cells with high CD24 expression by macrophages.8 Siglec-10 binds to CD24 in a sialic acid-dependent manner. This evidence concerns the gene CD24 and neoplasm.